New York. According to a large study, asthma patients whose disease is well controlled are less likely to have severe COVID-19 outcomes than those with uncontrolled asthma. The findings, published in The Journal of Allergy and Clinical Immunology: In Practice, suggest that asthma patients especially those who require clinical care. They should continue to take their asthma medicines during the COVID-19 pandemic.
Anyone living with asthma should continue to work with their health care provider to make sure they don’t know how to manage their asthma, said Zhanghua Chen, MD, assistant professor of population and public health sciences at the University of Southern California’s Keck School of Medicine. The best treatment is getting, which leads to better asthma control and less chance of serious COVID-19 outcomes.
Researchers gathered data on 61,338 COVID-19 patients from March 1 to August 31, 2020, using electronic medical records from Kaiser Permanente Southern California.
The medical code was used to determine whether these patients had asthma or chronic obstructive pulmonary disease prior to their COVID-19 diagnosis. The researchers further separated the data, with an ‘active’ group accounting for any patients who had had a clinical visit for asthma within the past 12 months, and an ‘inactive’ group accounting for those who did not.
Patients in the active asthma group were significantly more likely to require hospitalization, intensive respiratory support and ICU admission within 30 days of COVID-19 diagnosis than those with no history of asthma or COPD.
Specifically, the researchers did not see a higher probability of mortality within 60 days for the active asthma group.
Jiang, of Kaiser Permanente Southern California Department of Research, said the study went beyond examining the impact of asthma on COVID-19 outcomes and instead how COVID-19 outcomes for asthma patients based on their level of asthma control. Can change, focused on it.
Jiang said, we also saw that even in patients with active asthma, if they were using asthma medications, they were less likely to have a worsened COVID-19 outcome, which shows how important these drugs are. . (IANS)
read this also – Click to read the news of your state / city before the newspaper